Skip to content

Methods to determine the dialysis dose in clinical application

Methods to determine the dialysis dose in clinical application - MeDos

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000499
Enrollment
1000
Registered
2010-07-27
Start date
2007-10-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z49

Interventions

Group 1:

Sponsors

Fresenius Medical Care Deutschland GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adult haemodialysis patient - Signed informed consent - Physical and mental ability to participate in the study - Double-needle dialysis - Haemodialysis or on-line Haemodiafiltration

Exclusion criteria

Exclusion criteria: - Pregnancy in case of female patient - Pace maker - Implanted pump - Major amputation of arm or leg

Design outcomes

Primary

MeasureTime frame
Simultaneous determination of dialysis dose with 3 different methods (Kt/V_Dau, KtV_OCM, Kt/V_BCM) once in each haemodialysis patient

Secondary

MeasureTime frame
Hydration status of haemodialysis patients by single BCM measurement

Countries

Czechia, Germany

Contacts

Public ContactRalf Wojke

Fresenius Medical Care Deutschland GmbH

ralf.wojke@fmc-ag.de+49 6172 6092316

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026